BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 3909553)

  • 1. In vivo assessment of the sensitivity of Plasmodium falciparum to sulphadoxine/pyrimethamine combination (Fansidar) in six localities in Tanzania where chloroquine-resistant P. falciparum has been detected.
    Kilimali VA; Mkufya AR
    Trans R Soc Trop Med Hyg; 1985; 79(4):482-3. PubMed ID: 3909553
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fansidar-resistant Plasmodium falciparum infection from Tanzania.
    Vleugels MP; Wetsteyn JC; Meuwissen JH
    Trop Geogr Med; 1982; 34(3):263-5. PubMed ID: 6758246
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A case of fansidar-resistant Plasmodium falciparum from Tanzania.
    De Geus A; Meuwissen JH; van Rijn A
    Trop Geogr Med; 1982; 34(3):261-3. PubMed ID: 6758245
    [No Abstract]   [Full Text] [Related]  

  • 4. The in vivo sensitivity of Plasmodium falciparum to chloroquine and to sulphadoxine-pyrimethamine combination in Ibadan, Nigeria.
    Olatunde A; Salako LA; Walker O
    Trans R Soc Trop Med Hyg; 1981; 75(6):848-50. PubMed ID: 7036438
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Combined chloroquine/Fansidar-resistant falciparum malaria appears in East Africa.
    Hess U; Timmermans PM; Jones M
    Am J Trop Med Hyg; 1983 Mar; 32(2):217-20. PubMed ID: 6340538
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Falciparum malaria resistant to chloroquine and fansidar: implications for prophylaxis.
    Herzog C; Kibbler CC; Ellis CJ; Mtawali CV
    Br Med J (Clin Res Ed); 1983 Oct; 287(6397):947-8. PubMed ID: 6412900
    [No Abstract]   [Full Text] [Related]  

  • 7. Sensitivity in vivo of Plasmodium falciparum to chloroquine and pyrimethamine/sulfadoxine in a coastal area of Tanzania.
    Hedman P; Rombo L; Björkman A; Brohult J; Kihamia CM; Potter J; Stenbeck J
    Ann Trop Med Parasitol; 1986 Feb; 80(1):7-11. PubMed ID: 3524485
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Kenyan chloroquin, fansidar and quninine resistant P. Falciparum.
    Turner GD
    Cent Afr J Med; 1984 Jul; 30(7):136-7. PubMed ID: 6386173
    [No Abstract]   [Full Text] [Related]  

  • 9. Failures of combined chloroquine and Fansidar prophylaxis in American travelers to East Africa.
    Miller KD; Lobel HO; Pappaioanou M; Patchen LC; Churchill FC
    J Infect Dis; 1986 Oct; 154(4):689-91. PubMed ID: 3528321
    [No Abstract]   [Full Text] [Related]  

  • 10. [Effectiveness of treatment with chloroquine, fansidar and dabequin of Plasmodium falciparum carriers, residing in a hyperendemic focus of malaria (the city of Bagamoyo, Northeastern Tanzania)].
    Kuznetsov RL; Kilama V; Peĭn D; Kampbell SS; Stori D
    Med Parazitol (Mosk); 1985; (4):15-9. PubMed ID: 3903459
    [No Abstract]   [Full Text] [Related]  

  • 11. Chloroquine resistance in Plasmodium falciparum in KwaZulu, 1983-1988.
    Hansford CF
    S Afr Med J; 1989 Nov; 76(10):546-7. PubMed ID: 2686047
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fansidar resistant Plasmodium falciparum infection in Surinam.
    Oostburg BF; Jozefzoon LM
    Trop Geogr Med; 1983 Sep; 35(3):243-7. PubMed ID: 6359597
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fansidar resistant falciparum malaria acquired in South East Asia.
    Black F; Bygbjerg I; Effersøe P; Gomme G; Jepsen S; Jensen GA
    Trans R Soc Trop Med Hyg; 1981; 75(5):715-6. PubMed ID: 7036431
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of chloroquine, amodiaquine and pyrimethamine-sulfadoxine on Plasmodium falciparum gametocytemia.
    Strickland GT; Fox E; Sarwar M; Khaliq AA; Macdonald M
    Am J Trop Med Hyg; 1986 Mar; 35(2):259-62. PubMed ID: 3513644
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Need for malaria prophylaxis by travelers to areas with chloroquine-resistant Plasmodium falciparum.
    Centers for Disease Control (CDC)
    MMWR Morb Mortal Wkly Rep; 1986 Jan; 35(2):21-22, 27. PubMed ID: 3001495
    [No Abstract]   [Full Text] [Related]  

  • 16. Leads from the MMWR. Need for malaria prophylaxis by travelers to areas with chloroquine-resistant Plasmodium falciparum.
    JAMA; 1986 Feb; 255(5):597. PubMed ID: 3003409
    [No Abstract]   [Full Text] [Related]  

  • 17. Falciparum malaria resistant to chloroquine and Fansidar.
    Jaatinen M; Kihamia CM; McLarty DG
    Br Med J (Clin Res Ed); 1984 Jan; 288(6410):65. PubMed ID: 6418318
    [No Abstract]   [Full Text] [Related]  

  • 18. [Uncomplicated malaria attack in an area with high resistance to chloroquine. 3. The use of second-choice oral drug treatment].
    Hengy C; Eberlé F; Gazin P; Kouka-Bemba D; Gelas H; Jambou R
    Bull Soc Pathol Exot; 1990; 83(1):61-5. PubMed ID: 2190706
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vivo and in vitro susceptibility of Plasmodium falciparum to sulphadoxine/pyrimethamine in Liberia, West Africa.
    Björkman A; Willcox M
    Trans R Soc Trop Med Hyg; 1986; 80(4):572-4. PubMed ID: 3544359
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Compared response to chloroquine, fansidar, quinine, and quinidine slow release of infections with Plasmodium falciparum in the Kivu region of Zaire.
    Delacollette C; Cibanguka J; Buregea H; Nkera J
    Acta Leiden; 1987; 55():159-62. PubMed ID: 3321832
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.